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Abstract
Aminosalicylates, corticosteroids and immunosuppressants are currently the therapeutic
choices in inflammatory bowel diseases (IBD), however, with limited remission and often se-
rious side effects. Meanwhile complementary and alternative medicine (CAM) use is in-
creasing, particularly herbal medicine. Boswellia serrata is a traditional Ayurvedic remedy
with anti-inflammatory properties, of interest for its usefulness in IBDs. The mechanism of
this pharmacological potential of Boswellia serrata was investigated in colonic epithelial cell
monolayers exposed to H2O2 or INF-γ+TNF-α, chosen as in vitro experimental model of in-
testinal inflammation. The barrier function was evaluated by the transepithelial electrical re-
sistance (TEER) and paracellular permeability assay, and by the tight junction proteins
(zonula occludens-1, ZO-1 and occludin) immunofluorescence. The expression of phos-
phorylated NF-κB and reactive oxygen species (ROS) generation were determined by im-
munoblot and cytofluorimetric assay, respectively. Boswellia serrata oleo-gum extract
(BSE) and its pure derivative acetyl-11-keto-β-boswellic acid (AKBA), were tested at 0.1-
10 μg/ml and 0.027μg/ml, respectively. BSE and AKBA safety was demonstrated by no al-
teration of intestinal cell viability and barrier function and integrity biomarkers. H2O2 or INF-γ
+TNF-α treatment of Caco-2 cell monolayers significantly reduced TEER, increased para-
cellular permeability and caused the disassembly of tight junction proteins occludin and ZO-
1. BSE and AKBA pretreatment significantly prevented functional and morphological alter-
ations and also the NF-κB phosphorylation induced by the inflammatory stimuli. At the
same concentrations BSE and AKBA counteracted the increase of ROS caused by H2O2
exposure. Data showed the positive correlation of the antioxidant activity with the mecha-
nism involved in the physiologic maintenance of the integrity and function of the intestinal
epithelium. This study elucidates the pharmacological mechanisms mediated by BSE, in
protecting intestinal epithelial barrier from inflammatory damage and supports its use as
safe adjuvant in patients affected by IBD.
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Introduction
Inflammatory bowel diseases (IBD), mainly Crohn's disease and ulcerative colitis, affect more
than 4 million people in the world, with a clinical onset typically between 15 and 45 years, be-
coming a clinical challenge in terms of treatments [1, 2]. Microbiota, genetic, and immunologi-
cal factors are involved in the etiopathogenesis of IBDs and the intestinal barrier dysfunction is
the main feature causing leak flux diarrhea and facilitating uptake of noxious antigens [3–5].
Aminosalicylates and glucocorticosteroids are current therapy to control inflammation and
symptoms. However, in severe cases immunosuppressive drugs, such as azathioprine, 6-mer-
captopurine, cyclosporine or anti-TNF αmonoclonal antibody are prescribed regardless the
adverse complications and the limited remission [6, 7]. Thus, complementary and alternative
medicine (CAM) use is increasing, particularly herbal medicine, as safe anti-oxidant/anti-in-
flammatory therapeutic option in IBD patients [8, 9]. Indeed, from one hand, oxidative injury
is relevant in the initiation and progression of barrier dysfunction, due to the enhanced pro-
duction of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in intestinal mu-
cosa, mainly triggered by neutrophils and activated leukocytes, causing lipid peroxidation,
protein modification and pro-inflammatory cytokines production [10]. On the other hand, the
release of TNF-α and INF-γ induces intestinal damage in IBD, such as changes in tight junc-
tion (TJ) structures, apoptosis and enhanced bacterial translocation [11], that can be repro-
duced in cell and animal experimental models.
Boswellia serrata oleo-gum resin, a traditional Ayurvedic remedy for inflammatory diseases
also known as Salai Guggal, Indian olibanu, Indian frankincense, is obtained from Boswellia
genus (Family Burseraceae). Boswellia antioxidant/antinflammatory properties have been stud-
ied for the pharmacological potential in arthritis, asthma, colitis and cancer [12–16]. The phy-
tochemical content of Boswellia serrata oleo-gum resin is dependent on the botanical origin
and consists of 30–60% triterpenes (such as α- and β-boswellic acids, lupeolic acid), 5–10% es-
sential oils, and polysaccharides. The 11-keto-β-boswellic acid (KBA) and acetyl-11-keto-β-
boswellic acid (AKBA) have been considered as the main active derivatives [17], and several
mechanisms of action have been demonstrated: inhibition of 5-lipoxygenase (5-LO), effects on
immune system, such as decreased cytokines (interleukins and TNF-α) levels and diminished
complement system and leukocyte elastase activities, reduction of ROS formation and P-selec-
tin-mediated recruitment of inflammatory cells [18–20]. However, other components of the
oleo-gum resin, such as β-boswellic acid, have been suggested as anti-inflammatory agents, act-
ing through inhibition of serine protease cathepsin G and microsomal prostaglandin E
synthase [17]. Since the therapeutic potential of Boswellia in IBD is still under debate, in this
study Boswellia serrata oleo-gum resin extract (BSE) and its derivative AKBA were evaluated
in Caco-2 cell monolayer exposed to H2O2 or to INF-γ+TNF-α, chosen as experimental model
of endogenous inflammatory stimuli [21]. Functional, morphological and molecular biomark-
ers of intestinal barrier integrity were investigated.
Material and Methods
HPLC-MS and HPLC-DAD-ELSD analyses
Qualitative and quantitative constituents of BSE (resin dry extract water/ethanol 60/40 V/V
kindly provided by EOS, Treviso, Italy) were performed by high-performance liquid chroma-
tography-tandem mass spectrometry (HPLC-MS) and high-performance liquid chromatogra-
phy coupled with a diode array detector and an evaporative light scattering detector
(HPLC-DAD-ELSD). BSE (50 mg) was dissolved in 15 ml of methanol using an ultrasound
bath for 10 minutes. After centrifugation (5 min at 3000 rpm), the solid residue was extracted
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again with 10 ml of methanol in ultrasound bath for 10 min, centrifuged, and the supernatant
collected to 100 ml with the same solvent. A portion of the solution was filtered through
0.45 μmmembrane and used for HPLC analysis.
For HPLC-MS analysis a Varian 212 binary chromatograph equipped with 500MS ion trap
and Prostar 430 autosampler was used (Varian Inc., USA). For the HPLC-DAD-ELSD analysis
an Agilent 1100 Series chromatograph with 1100 Diode Array detector and Sedex LX 60 Evap-
orative Light Scattering Detector (ELSD) was used. As stationary phase an Agilent Eclipse
XDB-C8 2.1 x 150 mm, 3.5 μm (Agilent Tecnologies, USA) was used. The mobile phase was
composed of methanol (A) and water with 0.1% formic acid (B) and the gradient phases were:
70% A to 100% A in 10 minutes, then isocratic phase until 30 minutes. Re-equilibration time
was from 31 to 44 minutes. The flow was 200 μl/min and the injected volume was 10 μl. The
same column and gradient were used both in the HPLC-MS and HPLC-DAD-ELSD systems.
The MS parameter were: positive ion mode, 84 Volt capillary voltage, 50–2000 m/z of spectral
range, RF loading 70%, nebulizing gas Nitrogen pressure 25 psi, drying gas temperature 350°C
and drying gas pressure 15 psi, spray shield 600 volt. Triterpenes were identified on the basis of
their MS spectra and comparison with the literature. For the quantitative determination, 5–-
150 μg/mL solutions of 11-acetyl-α-keto boswellic acid (AKBA, Extrasynthese, France) were
prepared. Calibration curve was obtained measuring the peak area at 260 nm with the DAD de-
tector. The equation of the curve was y = 0.0187x+ 0.5218 and R2 was 0.9999. The ELSD was
used as detector of signals also from triterpene lacking the chromophore groups. A calibration
curve was obtained (y = 0.0232 x2 + 0.23 x+ 0.0022; R2 = 0.9998) also with the ELSD and the
total amount of triterpene was calculated using AKBA as reference compound.
Intestinal cell monolayer preparation and treatment
LoVo and HT29 cells were purchased from American Type Culture Collection (Manassas, VA,
USA) and grown in Roswell Park Memorial Institute medium (RPMI 1640) whereas Caco-2
cells, obtained from American Type Culture Collection, were grown in high-glucose Dulbec-
co’s modified Eagle’s media (DMEM). grown in high-glucose Dulbecco’s modified Eagle’s
media (DMEM). Medium was supplemented with 10% Fetal Bovine Serum (FBS), 2% L-gluta-
mine and 1% penicillin/streptomycin. Cells were maintained under a humidified atmosphere
of 5% CO2 in air, incubator at 37°C. Experimental inflammatory condition in Caco-2 cell
monolayers was induced by the exposure for different times according to the assays, to 500 μM
H2O2 or to 2.5 ng/ml recombinant human IFN-γ for 3 hours and then 10 ng/ml TNF-α were
added. Twenty-four hours pre-treatment with BSE (0.1–1 μg/ml) or AKBA (0.027 μg/ml) was
applied before the inflammatory stimuli. Reagents for cell cultures were from Cambrex-Lonza
(Basel, Switzerland), whereas INF-γ and TNF-α were from R&D Systems (Minneapolis, USA).
Cell viability assay
Cell viability was determined by the 3-(4,5-dimethyl- thiazole-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay, as previously described [22]. Briefly, LoVo, HT-29 and Caco-2 cells
were seeded in 96-multiwells culture plates and treated with BSE (0.1–10 μg/ml) or AKBA
(0.027 μg/ml) for 24, 48 or72 hours. The formazan absorbance was measured at 570 nm, using
a Multilabel Plate Reader VICTOR X3 (PerkinElmer).
ROS fluorescence assay
ROS were quantified using 20,70-dichlorofluorescin-diacetate (H2-DCF-DA, Sigma-Aldrich), as
previously described [23]. Upon cleavage of the acetate groups by intracellular esterase and oxi-
dation, the H2-DCF-DA is converted to the fluorescent 2',7'-dichlorofluorescein (DCF). Briefly,
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the intestinal cells (5×103) were seeded into 96-well plates and allowed to adhere overnight.
ROS level was measured after the exposure to BSE or AKBA for 24 hours, in the absence or
presence of 500 μMH2O2, and subsequent addition of 10 μMH2-DCF-DA, further incubation
for 30 min at 37°C and washing with phosphate-buffered saline (PBS). DCF fluorescence inten-
sity was measured at excitation 485 nm—emission 535 nm, using a Multilabel Plate Reader
VICTOR X3 (PerkinElmer). Fold increase in ROS production was calculated using the equa-
tion: (Ftreatment—Fblank)/(Fcontrol—Fblank), where F is the fluorescence reading.
Trans-epithelial electrical resistance (TEER) assay
Caco-2 cell cultures were performed essentially as previously described [24]. Briefly, the cells
were seeded on Transwell polyester membrane cell culture inserts (transparent PET mem-
brane: 1.0 cm2 growth surface area, 0.4 μm pore size; BD Falcon) in 24-well plates and incubat-
ed with the appropriate culture media at 37°C in a humidified atmosphere and 5% CO2.
Culture media were replaced every day until confluent monolayer was obtained. The TEER
assay was performed in HBBS (Hanks’ Balanced Salt solution, Cambrex-Lonza, Basel, Switzer-
land) after an equilibration period at room temperature. Treatments were added to the basal
chamber without manipulating the apical media. Millicell ERS meter, Millipore Corporation
(Bedford, MA) connected to a pair of chopstick electrodes were inserted in the donor and re-
ceiver chambers and the 24 hours-time course of TEER variation was recorded. TEER was ex-
pressed as percentage of resistance, normalized to initial value.
Paracellular permeability assay
Sodium fluorescein flux across Caco-2 cell monolayers was used as a measure of the paracellular
permeability. Caco-2 cell culture were used essentially as previously described [25]. Briefly, the
cells were seeded on Transwell polyester membrane cell culture inserts (transparent PET mem-
brane: 1.0 cm2 growth surface area, 0.4 μm pore size; BD Falcon) in a 24-well plate with the ap-
propriate medium. The cells were incubated at 37°C in a humidified atmosphere of 5% CO2
and confluent monolayers were obtained within 20–21 days. Culture media were replaced every
day. 200 μl of HBBS (Hanks’ Balanced Salt solution, Cambrex-Lonza, Basel, Switzerland) con-
taining 1 mg/ml sodium fluorescein were added to the apical side of each monolayer chamber.
At the end of experimental protocols, the amount of fluorescein permeation to the basolateral
side of the chamber was measured using a Multilabel Plate Reader VICTOR X3 (PerkinElmer)
at excitation 480 nm—emission 530 nm.
Immunofluorescence microscopy
At the end of the experimental protocols cells were collected by trypsinization and centrifuga-
tion, washed with PBS, seeded on glass coverslips in 6-well plates and cultured until reached ap-
proximately 30% confluence. For detection of ZO-1 and occludin TJ proteins, cells were fixed
with 4% formaldehyde, permeabilized with 0.1% Triton X-100 in PBS and stained with a mouse
monoclonal anti-occludin or with a rabbit polyclonal anti-ZO-1 (Invitrogen Life Technologies,
Milan, Italy). After PBS wash, they were incubated with secondary antibodies/fluorescein iso-
thiocyanate (Alexa Fluor 488 anti-mouse or Alexa Fluor 536 anti-rabbit immunoglobulin G,
Molecular Probes, Invitrogen, Milan, Italy) for 1 hour at room temperature. The coverslips
were mounted on glass slides by using Mowiol 40–88 (Sigma, St Louis, MO). Images were ac-
quired through a ×60 CFI Plan Apochromat Nikon objectives with a Nikon C1 confocal micro-
scope and finally analysed using NIS Elements software (Nikon Instruments, Florence, Italy),
NIH Image J and Adobe Photoshop CS4 version 11.0.2.
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NF-κB immunoblot and chemiluminescence analysis
At the end of the experimental protocol Caco-2 cell monolayers were washed twice in ice-cold
PBS and then lysed (45 min on ice) using nondenaturing RIPA buffer (150 mMNaCl, 50 mM
Tris-HCl, 0.25% sodium deoxycholate, 0.1% Nonidet P-40, 100 μMNaVO4, 1mMNaF, 1 mM
phenylmethylsulfonyl fluoride, 10 μg/ml aprotinin, 10 μg/ml leupeptin from Sigma, St Louis,
MO, USA). Particulate material was removed by centrifugation (15000 x g for 5 min at 4°C).
Supernatants were collected and protein concentrations were determined using the bicinchoni-
nic acid method (Pierce, Rockford, IL, USA). Twenty-five μg of total proteins were fractionated
through a 7.5% p/v SDS-PAGE gel and then transferred and immobilized onto a nitrocellulose
membrane. Membranes were blocked for 20 min at room temperature in 5% skim milk (Onco-
gene, Cambridge, MA, USA) in PBS containing 0.05% v/v Tween-20. After washes, membranes
were incubated for 16 hours at 4°C with mouse anti-phospho-NF-κB p65 antibody (7F1, Cell
Signaling, Danvers, MA, USA). Bound antibody was detected by incubation with HRP-conju-
gated goat anti-mouse IgG antibody. Bands were visualized using enhanced chemilumines-
cence (Millipore, Billerica, MA, USA). Images were captured using a Hyper Film MP (GE
Healthcare, Milan, Italy) and densitometry was performed using NIH Image J software.
Statistical Analysis
The statistical analysis was performed using GraphPad Prism version 3 for Windows (Graph-
Pad Software, San Diego, CA, USA). Unless stated otherwise, results are presented as mean
±SEM. The unpaired t-test was used to compare ROS intracellular level, paracellular perme-
ability and NF-κB phosphorylation in different experimental conditions. P values<0.05 were
considered statistically significant. ANOVA followed by a post-hoc test (Dunnett's test or
Tukey’s test for multiple comparisons) were used to statistically evaluate trans-epithelial elec-
trical resistance (TEER) variations during 24 hours of different treatments.
Results
HPLC-MS and HPLC-DAD-ELSD quali-quantitative analysis of BSE
The anti-inflammatory properties of Boswellia serrata are also attributed to 11-keto-β-boswellic
acid (KBA) and 3-acetyl-11-keto-β-boswellic acid (AKBA), even if other boswellic acids, such
as β-boswellic acid (βBA) might be efficacious. Therefore, the first step of our study was to mea-
sure BSE triterpene content by HPLC-MS and HPLC-DAD-ELSD procedures. Results, summa-
rized in Table 1, show that triterpene derivatives composed the 39% of total BSE where KBA
and AKBA, in particular, resulted to be at the percentage of 5.02% and 2.71%, respectively.
BSE and AKBA do not affect intestinal cell viability
Caco-2, LoVo and HT-29 intestinal epithelial cell monolayers were treated for 24, 48 and 72
hours with BSE (0.01–10 μg/ml) or with AKBA (0.027μg/ml, corresponding to 2.7% of AKBA
present in 1 μg/ml of BSE). Cell viability was assessed by MTT assay and Fig 1 shows that both
BSE and AKBA did not affect the viability of the three types of intestinal cell lines.
BSE and AKBA prevent the dysfunction of trans-epithelial electrical
resistance and paracellular permeability caused by oxidative/
inflammatory stimuli
Since uncontrolled or dysregulated gut epithelial permeability in overactive mucosal immune
response and chronic intestinal inflammation has been proposed as primary defects in IBD,
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TEER and paracellular permeability are considered specific and sensitive biomarkers of the in-
testinal barrier integrity and function [24, 25]. Thus, the effect of BSE (0.1μg/ml, 1μg/ml) or
AKBA (0.027 μg/ml) was measured on TEER and permeability in Caco-2 cell monolayer in
basal condition and after exposure to H2O2 or to INF-γ+TNF-α (Fig 2).
Twenty-four hours of BSE or AKBA treatment did not cause any alteration of basal TEER
(Fig 2A) whereas 24 hours-exposure to 500 μMH2O2 determined a time-dependent reduction
of more than 50% of TEER T0 value (Fig 2B). This effect was significantly prevented by BSE or
AKBA pretreatment (p = 0.003 and p = 0.0043, respectively, ANOVA followed by Dunnett’s
test towards H2O2). INF-γ + TNF-α treatment also significantly decreased TER T0 value
(p = 0.0003; Fig 2C) and BSE or AKBA prevented also in this case the intestinal cell polarity re-
duction (p = 0.02; Fig 2C).
Sodium fluorescein is a validated biomarker of leakage used in the paracellular permeability
assay [26]. The assay was applied to evaluate the effect of inflammatory stimuli in presence of
absence of BSE and AKBA treatment in Caco-2 cell monolayer (Fig 3). BSE and AKBA did not
influence the cell permeability in basal condition (Fig 3A). However, H2O2 and INF-γ+TNF-α
increased basal values more than three-fold (p<0.0001) and more than two fold (p = 0.005),
respectively (Fig 3B and 3C). When Caco-2 cell monolayers were pretreated with BSE and
AKBA, the alteration of paracellular permeability induced by inflammatory stimuli was signifi-
cantly counteracted (p<0.0001).
BSE and AKBA prevent TJ disruption induced by oxidative and
inflammatory stimuli
ZO-1 and occludin belong to TJ proteins that form a continuous, circumferential, belt-like
structure at the boundary between the apical and basolateral membrane domains in epithelial
and endothelial cells. By constituting a regulated diffusion barrier, TJs establish separate com-
partments, that are crucial for the exchange of substances through the paracellular pathway,
and are considered useful biomarkers of the epithelial barrier function/dysfunction [11, 27].
Therefore the effect of BSE and AKBA on ZO-1 and occludin was studied as possible mecha-
nism involved in protection from inflammatory damage. Results in Fig 4 show that in
Table 1. Main triterpene content in the BSE: retention time (Rt), adduction ion ([M + H]+, formed by the
interaction of the molecule with a proton), and percentage amount.
Rt Compound [M+H]+ % in BSE
10.0 11-keto-β-boswellic acid (KBA) 471 5.02± 0.09
11.0 3-O-acetyl-11-keto-β-boswellic acid (AKBA) 513 2.71 ± 0.09
11.3 9,11-dehydro-α-boswellic acid 455 4.40 ± 0.04
11.6 β-amirin 427 4.04 ± 0.06
12.3 9,11-dehydro-β-boswellic acid 455 4.68 ± 0.03
12.5 α-boswellic acid 457 1.40 ± 0.05
12.7 β-boswellic acid 457 0.94 ± 0.04
12.8 lupeolic acid 455 2.84 ± 0.06
11.8 3-O-acetyl-9,11-dehydro-α-boswellic acid 497 2.42 ± 0.02
12.1 3-O-acetyl-9,11-dehydro-β-boswellic acid 497 0.67 ± 0.05
12.2 ursanic acid 499 0.87 ± 0.03
12.9 3-O-acetyl-α-boswellic acid 499 1.77 ± 0.05
13.0 3-O-acetyl-β-boswellic acid 499 1.61 ± 0.02
Data are the mean ± SD of 3 determinations.
doi:10.1371/journal.pone.0125375.t001
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untreated Caco-2 cell monolayer ZO-1 and occludin immunofluorescence signals localize at
the apical membrane junctions, appearing as continuous belt-like structures encircling the cell.
This asset was not modified by BSE or AKBA treatments. By contrast, H2O2 (Fig 5) or INF-γ
+TNF-α (Fig 6) cause similar alteration of TJs. Particularly, in INF-γ+TNF-α treated cells it ap-
pears that occludin is striking internalized and that the staining of membrane ring structure is
irregular. These alterations in TJ proteins caused by the inflammatory stimuli was prevented
by both BSE and AKBA treatments.
Fig 1. Effect of BSE and AKBA on cell viability measured by MTT assay in Caco-2, LoVo and HT-29
intestinal epithelial cell lines. Results are mean ±SEM of n = 4 experiments and are expressed as
Absorbance Units and normalized to values in untreated cells (100%).
doi:10.1371/journal.pone.0125375.g001
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BSE and AKBA prevent NF-κB phosphorylation induced by oxidative/
inflammatory stimuli
The nuclear transcription factor NF-κB is a key player in the development and progression of
chronic inflammatory diseases by regulating a wide range of cytokines such as TNF-α and IL-
1β. In IBD patients, NF-κB is markedly induced, strongly influencing the course of mucosal in-
flammation [28]. To gain further insight into the molecular mechanism of BSE and AKBA,
their effect on NF-κB intracellular levels was investigated in Caco-2 cell monolayers after 24
hours of exposure to inflammatory condition (H2O2 or INFγ + TNFα). Fig 7 shows that BSE
and AKBA per se did not alter the NF-κB phosphorylation level, whereas, as expected, H2O2
and INF-γ+TNF-α treatment caused a significant increase of it. Interestingly, pre-treatment
with BSE and AKBA positively and significantly counteracted this event.
BSE and AKBA counteract the ROS generation induced by H2O2
Abnormally high levels of ROS are produced in IBD and their destructive effects may contrib-
ute to the initiation and/or propagation of tissue damage [10, 29]. The antioxidant activity of
Fig 2. Effect of BSE and AKBA on transepithelial electrical resistance (TEER) in Caco-2 cell
monolayers. A) BSE and AKBA; B) BSE and AKBA with H2O2 (
+++p<0.001 H2O2 vs control. ***p<0.001
BSE and AKBA vs H2O2 **p<0.01 BSE and AKBA vs H2O2); C) BSE or AKBA with INFγ+TNFα (
++p<0.01
INF-γ+TNF-α vs control ***p<0.001 BSE and AKBA vs INF-γ+TNF-α **p<0.01 BSE and AKBA vs INF-γ
+TNF-α). Data are expressed as mean ± SEM percentage of baseline TEER value of n = 3 experiments.
doi:10.1371/journal.pone.0125375.g002
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BSE and AKBA was assayed in Caco-2 cell monolayers immediately after the exposure to H2O2
stimuli. Results in Fig 8 show that BSE and AKBA not only reduced the basal intracellular ROS
levels, even if not significantly, but also they significantly counteracted the increased ROS gen-
eration induced by the oxidative stimulus (p = 0.05).
Fig 3. Effect of BSE and AKBA on Caco-2 cell monolayers paracellular permeability, measured by
sodium fluorescein assay. A) basal condition. B) BSE and AKBA + H2O2 (
+++p<0.001 H2O2 vs control
***p<0.001 BSE and AKBA vs H2O2 **p<0.01 BSE and AKBA vs H2O2). C) BSE and AKBA + INF-γ+TNF-α.
(+++p<0.001 INFγ+TNFα vs control +p<0.05 INF-γ+TNF-α vs control ***p<0.001 BSE and AKBA vs INF-γ
+TNF-α). Data are shown as mean ± SEM percentage of basal fluorescent intensity (FI) of n = 3 experiments.
doi:10.1371/journal.pone.0125375.g003
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Discussion
In Caco-2 cell monolayers BSE and its pure derivative AKBA are able to preserve the intestinal
barrier integrity and function from damages caused by H2O2 or INF-γ+TNF-α inflammatory
stimuli. Comparing the quality and the potency of their pharmacological effects it can be as-
sumed that the activity of BSE is mainly due to AKBA.
The inflammation is crucial in gut barrier dysruption in IBD [29–32] and despite Boswellia
serrata is included among several natural anti-inflammatory compounds, its efficacy in IBD is
still debated, stimulating further investigation on its mechanism of action [17, 33, 34].
The Boswellia serrata gum extract used in this study was profiled by HPLC-MS and
HPLC-DAD-ELSD procedures to determine the triterpene content. The results showed a
Fig 4. BSE and AKBA effect on occludin and zonula occludens (ZO1) TJ proteins in Caco-2 cell
monolayers. BSE and AKBA did not affect basal fluorescent signal of anti-ZO-1 (red) and anti-occludin
(green). Images were collected by confocal laser-scanning microscope and are representative of 3
independent experiments. Scale bar = 10 μm.
doi:10.1371/journal.pone.0125375.g004
Fig 5. BSE and AKBA ameliorate alterations following exposure to H2O2 occludin and zonula
occludens (ZO1) TJ proteins in Caco-2 cell monolayers. Double immunostaining showing the distribution
of ZO-1 (red) and occludin (green). Images were collected by confocal laser-scanning microscope and are
representative of 3 independent experiments. Scale bar = 10 μm.
doi:10.1371/journal.pone.0125375.g005
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Fig 6. BSE and AKBA ameliorate alterations induced by INF-γ+TNF-α on zonula occludens (ZO1) and
occludin TJ proteins in Caco-2 cell monolayers. Double immunostaining showing the distribution of ZO-1
(red) and occludin (green). Images were collected by confocal laser-scanning microscope and are
representative of 3 independent experiments. Scale bar = 10 μm.
doi:10.1371/journal.pone.0125375.g006
Fig 7. BSE and AKBA effect on NF-kB intracellular level in Caco-2 cells. A) basal condition; B) BSE and AKBA + 4 hours with H2O2
+++ p<0.001 H2O2 vs
control. *** p<0.001 BSE and AKBA vs H2O2 ** p<0.01 BSE and AKBA vs H2O2. C) 24 hours pretreatment with BSE and AKBA + 4h with INF-γ+TNF-α as
described in method. +++p<0.001 INFγ+TNFα vs control +p<0.05 INFγ+TNFα vs control ***p<0.001 BSE and AKBA vs INF-γ+TNF-α. Data are shown as
mean ± SEM percentage of control optical density (OD) of n = 3 experiments.
doi:10.1371/journal.pone.0125375.g007
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nearly 34% amount of pentacyclic triterpenes, and AKBA is the compound present at 2.71.%,
according to the literature [35]. The safety of BSE and AKBA was demonstrated by unaltered
cell viability, cell polarity, paracellular permeability and TJs, biomarkers of intestinal barrier
function and integrity. Thereafter Caco-2 cells exposed to INF-γ+TNF-α or H2O2 were chosen
as convenient experimental paradigm of intestinal inflammation, for specific reasons. Caco-2
immortalized cells are an invaluable reductionist model for studying the epithelial barrier and
TJ integrity, resembling many of the morphologic and functional attributes of the intestinal ep-
ithelium [36–38]. Pro-inflammatory cytokines and ROS contribute to the initiation and/or
propagation of damage within the mucosal intestinal barrier in IBD, and they may be used to
reproduce in cell cultures comparable endogenous inflammation [10, 29, 39, 40]. Indeed, when
we exposed the Caco-2 cell monolayer to INF-γ+TNF-α or H2O2 results showed significant de-
crease of the cell polarity (TEER) and increase of the paracellular permeability. Interestingly,
these alterations were significantly prevented by pre-treatment with BSE or AKBA.
In human gut a single layer of epithelial cells separates the intestinal lumen from the underly-
ing lamina propria, and the space between these cells is sealed by TJ proteins, such as occludin,
ZO-1 and claudins [11, 27, 41]. TJs are essential to maintain physiologic processes in all organs
containing epithelia and critical in the intestinal barrier, where they modulate the cell polarity,
proliferation, and differentiation [42]. The occludin and ZO-1 delocalization from the TJs is as-
sociated with intestinal barrier dysfunction and increased permeability [27, 43]. Various stimuli,
including pathogens, oxidative stress, and pro-inflammatory cytokines can affect TJs proteins
[11,39], such as TNF-α and IFN-γ re-distribution processes inducing in cell culture and in ani-
mal models comparable barrier defects as observed in IBD [40, 44, 45]. According to the litera-
ture, our results demonstrated that INF-γ+TNF-α as well H2O2 caused occludin and ZO-1
disruption on Caco-2 cell membrane and BSE or AKBA efficaciously prevented TJs disassembly.
It has been shown that the increase of intestinal TJ permeability as well as other TNF-α -in-
duced genes are NF-κB-dependent, the relevant transcription factor in inflammatory process
[46, 47]. In our experiments INF-γ+TNF-α and H2O2 exposure caused NF-κB increase in
Caco-2 cell monolayers and this activation was significantly counteracted by BSE and AKBA,
indicating the possibility of the natural compounds to down-regulate the intestinal response to
chronic inflammatory stimuli. Finally, at the same concentration that ameliorates the intestinal
damage induced by inflammatory stimuli, BSE and AKBA prevented the ROS intracellular
Fig 8. Effect of BSE and AKBA on ROS level in Caco-2 cells. ROSwere measured after 24 hours of
incubation in untreated cells and after 500 μMH2O2 exposure.Data are expressed as mean ± SEM
percentage of basal (100%) DCF fluorescence intensity (FI) of n = 4 experiments. *p<0.05 BSE or AKBA vs
H2O2.
doi:10.1371/journal.pone.0125375.g008
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increase induced following exposure to H2O2. Our results in vitro are in accordance with re-
duced lipid peroxidation, nitric oxide and iNOS as recently shown by Boswellia serrata in acute
experimental ulcerative colitis experiments [48]. It is known that intact intestinal epithelial bar-
rier but also endogenous antioxidant defence prevent pathogens and antigenic molecules from
coming into the mucosa and contacting the immune system; however in some tissue, such as
colon, the antioxidant capacity is low and it may facilitate inflammatory injury [49]. Therefore,
it can be supposed that this low endogenous antioxidant defence might be overcome by Boswel-
lia, thus balancing the several mechanisms involved in the intestinal maintenance and preser-
vation from inflammatory damage.
Kiela et al. [50] observed no benefit to disease severity in both the dextran sulphate sodium-
or trinitrobenzene sulfonic acid-induced models of colitis where mice were fed with a diet en-
riched with either hexane or methanolic Boswellia extracts. These authors also reported that
boswellic acids (50 μM) increased basal and IL-1β-stimulated NF-κB activity in Caco-2 cells
transiently transfected with NF-κB reporter plasmid, and considered this effect possibly associ-
ated to oxidative stress. However, some differences characterize our in vitromodel and experi-
mental design from the aforementioned report. In our study, different in vitro inflammatory
model and lower concentrations of boswellic acids were used as well as a longer time of expo-
sure compared with the study by Kiela et al. [50]. Whether these differences in the treatment
with BSE and AKBA account for the discordant anti-inflammatory responses to these agents
remains unclear but underline the relevance of specific cellular/tissue antioxidant state and the
need for a systematic evaluation of the influence of these factors on therapeutic efficacy of Bos-
wellia serrata gum extract in different models of in vitro and in vivo intestinal inflammation.
Indeed, in the last few years it has become evident that persistent dysregulation of redox status
contributes to the intensity and duration of the inflammatory response and is involved in the
pathogenesis of chronic disease states; therefore the identification of natural compounds as reg-
ulators of inflammatory signalling is critical in the discovery of novel therapeutics [51]. There-
fore, targeting the re-establishment of intestinal barrier function is still a challenge in acute or
chronic enteropathies and the specific functional, morphological and molecular mechanisms
in colonic cell lines of Boswellia herein demonstrated in Caco-2 cell lines, support its use as safe
adjuvant in IBD therapeutic strategies.
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